Chennai-based pharma company Orchid Chemicals & Pharmaceuticals has announced that it has received approval from the US FDA for its abbreviated new drug application for Levofloxacin tablets in the 250 mg, 500 mg and 750 mg strength. Levofloxacin is used to treat severe bacterial infections. The company's shares dropped 0.17 per cent to end Thursday's trade at Rs 174 on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.